ResMed | RMD - Gross Profit On Sales

Stock Price
271.63
Daily Change
4.58 1.72%
Monthly
9.44%
Yearly
14.64%
Q1 Forecast
250.35

ResMed reported $878.72M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Ansell USD 326.2M 27.6M Jun/2024
AtriCure USD 101.33M 150K Sep/2025
Baxter International USD 950M 194M Sep/2025
Cochlear AUD 426.8M 454.9M Jun/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
CSL USD 1.75B 2.53B Jun/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Fisher Paykel Healthcare NZD 685.7M 3.5M Dec/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Medtronic USD 5.44B 123M Sep/2025
Philips EUR 1.91B 100M Sep/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 878.72M 57.9M Dec/2025
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Steris USD 655.5M 9.6M Dec/2025
Teleflex USD 451.64M 20.56M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025